Literature DB >> 30019520

Pulmonary interstitial glycogenosis: Diagnostic evaluation and clinical course.

Deborah R Liptzin1, Christopher D Baker1, Jeffrey R Darst1, Jason P Weinman2, Megan K Dishop3, Csaba Galambos4, John T Brinton5, Robin R Deterding1.   

Abstract

OBJECTIVES: We sought to describe the phenotype for patients with P.I.G. including presentation, evaluation, cardiac co-morbidities, high resolution computed tomography findings, and outcomes.
METHODS: With institutional review board approval, we performed a retrospective review of patients with biopsy-proven P.I.G. Biopsies, high resolution chest computed tomography, and cardiac evaluations were reviewed and characterized by experts in each field.
RESULTS: Sixty-two percent of the patients were male. The median gestational age was 37 weeks (range 27-40). The median age at biopsy was 1.6 months (range 0.3-6 months). Structural heart disease was present in 63% of patients. Pulmonary hypertension (diagnosed by echocardiogram and/or cardiac catheterization) was noted in 38% of patients. Alveolar simplification was present in 79% of patients. Fifty percent of available biopsies revealed patchy disease. An increase in age at biopsy was associated with patchy (vs diffuse) disease. Ninety-two percent of patients were treated with systemic corticosteroids. Median age at last follow-up was 1234 days with a range of 37 days to 15 years. At the time of last follow-up, 12 patients were off all support, eight were on supplemental oxygen, two were mechanically ventilated, one underwent lung transplantation, and one died. CT findings commonly included ground glass opacities (86%) and cystic change (50%).
CONCLUSIONS: The P.I.G. phenotype has not been comprehensively described, and poor recognition and misconceptions about P.I.G. persist. P.I.G. is a disease that presents in early infancy, requires significant medical intervention, and frequently is seen in association with alveolar simplification and/or cardiovascular disease. CT findings include ground glass opacities and cysts. Patients should be monitored for pulmonary hypertension. Without life-threatening comorbidities, many patients do well over time, although respiratory symptoms may persist into adolescence.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  biopsy; cysts; glucocorticords; infant newborn; interstitial lung diseases; oxygen; phenotype; pulmonary hypertension

Mesh:

Substances:

Year:  2018        PMID: 30019520      PMCID: PMC6456905          DOI: 10.1002/ppul.24123

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  20 in total

1.  Persistent tachypnea of infancy is associated with neuroendocrine cell hyperplasia.

Authors:  Robin R Deterding; Catherine Pye; Leland L Fan; Claire Langston
Journal:  Pediatr Pulmonol       Date:  2005-08

2.  Pulmonary interstitial glycogenosis in the setting of lung growth abnormality: radiographic and pathologic correlation.

Authors:  Monette Castillo; Aruna Vade; Jennifer Eden Lim-Dunham; Emi Masuda; Rasan Massarani-Wafai
Journal:  Pediatr Radiol       Date:  2010-05-04

3.  Persistent Tachypnea of Infancy. Usual and Aberrant.

Authors:  Daniela Rauch; Martin Wetzke; Simone Reu; Waltraud Wesselak; Andrea Schams; Meike Hengst; Birgit Kammer; Julia Ley-Zaporozhan; Matthias Kappler; Marijke Proesmans; Joanna Lange; Amparo Escribano; Eitan Kerem; Frank Ahrens; Frank Brasch; Nicolaus Schwerk; Matthias Griese
Journal:  Am J Respir Crit Care Med       Date:  2016-02-15       Impact factor: 21.405

4.  Cellular interstitial pneumonitis in infants. A clinicopathologic study.

Authors:  S A Schroeder; D C Shannon; E J Mark
Journal:  Chest       Date:  1992-04       Impact factor: 9.410

5.  Neuroendocrine cell hyperplasia of infancy: diagnosis with high-resolution CT.

Authors:  Alan S Brody; R Paul Guillerman; Thomas C Hay; Brandie D Wagner; Lisa R Young; Gail H Deutsch; Leland L Fan; Robin R Deterding
Journal:  AJR Am J Roentgenol       Date:  2010-01       Impact factor: 3.959

6.  High-resolution CT findings of pulmonary interstitial glycogenosis.

Authors:  Jason P Weinman; Christina J White; Deborah R Liptzin; Robin R Deterding; Csaba Galambos; Lorna P Browne
Journal:  Pediatr Radiol       Date:  2018-04-23

7.  Diffuse lung disease in infants less than 1 year of age: Histopathological diagnoses and clinical outcome.

Authors:  Ruth O'Reilly; David Kilner; Michael Ashworth; Paul Aurora
Journal:  Pediatr Pulmonol       Date:  2015-01-20

8.  Histologic resolution of pulmonary interstitial glycogenosis.

Authors:  Gail H Deutsch; Lisa R Young
Journal:  Pediatr Dev Pathol       Date:  2009 Nov-Dec

Review 9.  Pulmonary Hypertension in Preterm Infants with Bronchopulmonary Dysplasia.

Authors:  Christopher D Baker; Steven H Abman; Peter M Mourani
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2014-03-01       Impact factor: 1.349

Review 10.  The adverse neuro-developmental effects of postnatal steroids in the preterm infant: a systematic review of RCTs.

Authors:  K J Barrington
Journal:  BMC Pediatr       Date:  2001-02-27       Impact factor: 2.125

View more
  3 in total

1.  Persistence of persistent pulmonary hypertension of the newborn: A case of de novo TBX4 variant.

Authors:  Stephanie M Tsoi; Kirk Jones; Elizabeth Colglazier; Claire Parker; Hythem Nawaytou; David Teitel; Jeffrey R Fineman; Roberta L Keller
Journal:  Pulm Circ       Date:  2022-07-01       Impact factor: 2.886

2.  Transition of patients with interstitial lung disease from paediatric to adult care.

Authors:  Václav Koucký; Petr Pohunek; Martina Vašáková; Andrew Bush
Journal:  ERJ Open Res       Date:  2021-06-07

3.  Neonatal interstitial lung disease in a girl with Jacobsen syndrome: a case report.

Authors:  Marit Lunde Dalen; Natalya Filipchuk Vigerust; Clara Hammarström; Henrik Holmstrøm; Jannicke Hanne Andresen
Journal:  J Med Case Rep       Date:  2022-03-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.